Recent news highlights mixed fortunes for Goldman Sachs, including potential layoffs due to over-hiring and analyst downgrades impacting companies like Rocket Pharmaceuticals. Read more...

Wall Street is increasingly focused on AI, from adopting new technologies to facing scrutiny over AI-driven stock performance and short-seller battles. Explore how firms like Goldman Sachs and Blackstone are integrating AI and how companies like AppLovin are navigating AI's impact on their stock. Read more...

Recent analyst actions affect the stock outlook for Scotts Miracle-Gro (SMG), Titan America (TTAM), and Chipotle Mexican Grill (CMG). Get the latest ratings and target prices. Read more...

Political news includes Trump's stance on diversity, Zelensky's apology to the US, a potential US-Ukraine meeting in Saudi Arabia, a CNN correction, and the status of Ukrainian refugees in the US. Read more...

Score big savings with the latest deals from The RealReal, Brooklinen, and Vistaprint! Plus, an inside look at Goldman Sachs' cost-cutting plan and SBF's PR woes. Read more...

William Blair reaffirmed ratings for AvePoint and Biodesix, reiterated a "market perform" for Fortrea, and issued Q1 earnings forecast for Rocket Pharmaceuticals. Read more...

Okta (OKTA) receives multiple analyst upgrades and price target increases from firms like KeyCorp, DA Davidson, Mizuho, and Goldman Sachs, signaling strong market confidence. Read more...

This article covers recent news on AI trading platforms, Microsoft's cloud computing concerns, Uzbekistan's green transition, Goldman Sachs' AI investment advice, and a transatlantic flight mishap. Read more...

Reform UK faces legal challenges and increasing attention as it gains traction in UK politics, particularly concerning diversity policies and public service frustrations. Read more...